EKOS in Patients With Pulmonary Embolism (PE)

Beni-Suef University

Status: Completed

Conditions: Pulmonary Embolism

Treatments: Drug: Control group; Drug: ECOS

Study type: Observational

Funder types: Other

Identifiers

NCT06738108

ECOSII

Details and patient eligibility

About

A retrospective cohort study assessed patients who underwent EKOS intervention following the failure of initial therapeutic anticoagulation for managing acute pulmonary embolism at a tertiary hospital.

Full description

A retrospective cohort study assessed patients who underwent EKOS intervention following the failure of initial therapeutic anticoagulation for managing acute pulmonary embolism at a tertiary hospital. Patients aged at least 18 years with a diagnosis of submassive or massive acute PE were included. Patients were excluded if they either did not receive EKOS intervention or were presented with stable PE. The primary outcome was the change in RV/LV diameter ratio from baseline to first outpatient follow-up.

Enrollment: 104 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients ≥ 18 years diagnosed with massive or submassive acute PE.

Exclusion criteria

1. Patients presented with stable PE
2. Patients did not receive EKOS intervention.

Trial design

104 participants in 2 patient groups

ECOS group

Description:

ECOS

Treatment:

Drug: ECOS

Control group

Description:

IV infusion tpa

Treatment:

Drug: Control group